Activation of A2b adenosine receptor regulates ovarian cancer cell growth: Involvement of Bax/Bcl-2 and caspase-3

Biochemistry and Cell Biology

Volumn 93, Issue 4, 2015, Pages 321-329

  Hajiahmadi, Sima ^a   Panjehpour, Mojtaba ^a   Aghaei, Mahmoud ^a   Shabani, Mahdi ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

A2b adenosine receptor; Apoptosis; Mitochondrial pathway; Ovarian cancer

Indexed keywords

ACTIVATION ANALYSIS; ANTIBIOTICS; ASSAYS; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL MEMBRANES; CELL PROLIFERATION; CHEMICAL ACTIVATION; CYTOLOGY; DISEASES; GENE EXPRESSION; GROWTH KINETICS; MAGNESIUM PRINTING PLATES; MITOCHONDRIA; POLYMERASE CHAIN REACTION; PROTEINS;

ADENOSINE RECEPTOR; DOSE-DEPENDENT MANNER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PATHWAYS; MITOCHONDRIAL SIGNALING PATHWAYS; OVARIAN CANCERS; PROTEIN EXPRESSION LEVELS; PROTEIN EXPRESSION PROFILES;

CELLS;

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2B RECEPTOR; CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; ADENOSINE A2 RECEPTOR AGONIST; BAX PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; OVARY CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OVARIAN NEOPLASMS; RECEPTOR, ADENOSINE A2B;

EID: 84937849707     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0117     Document Type: Article

References (42)

1. Aghaei M. Panjehpour M. Karami-Tehrani F. Salami S. 2011. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway. J. Cancer Res. Clin. Oncol. 137 (10): 1511-1523. 10.1007/s00432-011-1031-z. 21830157.
2. Aghaei M. Karami-Tehrani F. Panjehpour M. Salami S. Fallahian F. 2012. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and-independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3. Prostate, 72 (4): 361-375. 10.1002/pros.21438. 21656837.
3. Baldwin J.M. 1994. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6 (2): 180-190. 10.1016/0955-0674(94)90134-1. 8024808.
4. Cekic C. Sag D. Li Y. Theodorescu D. Strieter R.M. Linden J. 2012. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J. Immunol. 188 (1): 198-205. 10.4049/jimmunol.1101845. 22116822.
5. Cory S. Adams J.M. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer, 2 (9): 647-656. 10.1038/nrc883. 12209154.
6. Dhillon A. Hagan S. Rath O. Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene, 26 (22): 3279-3290. 10.1038/sj.onc.1210421. 17496922.
7. Dubey R.K. Gillespie D.G. Jackson E.K. 1998 a. Adenosine Inhibits Collagen and Protein Synthesis in Cardiac Fibroblasts Role of A2B Receptors. Hypertension, 31 (4): 943-948. 10.1161/01.HYP.31.4.943. 9535419.
8. Dubey R.K. Gillespie D.G. Mi Z. Jackson E.K. 1998 b. Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. Hypertension, 31 (1): 516-521. 10.1161/01.HYP.31.1.516. 9453355.
9. Edwards B.K. Howe H.L. Ries L.A. Thun M.J. Rosenberg H.M. Yancik R. et al 2002. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer, 94 (10): 2766-2792. 10.1002/cncr.10593. 12173348.
10. El-Darahali A. Fawcett H. Mader J.S. Conrad D.M. Hoskin D.W. 2005. Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor. Exp. Mol. Pathol. 79 (3): 249-258. 10.1016/j.yexmp.2005.08.001. 16168410.
11. Fredholm B.B. IJzerman A.P. Jacobson K.A. Klotz K.-N. Linden J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (4): 527-552. 11734617.
12. Gessi S. Cattabriga E. Avitabile A. Lanza G. Cavazzini L. Bianchi N. et al 2004. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin. Cancer Res. 10 (17): 5895-5901. 10.1158/1078-0432.CCR-1134-03. 15355922.
13. Gessi S. Merighi S. Sacchetto V. Simioni C. Borea P.A. 2011. Adenosine receptors and cancer. Biochim. Biophys. Acta, 1808 (5): 1400-1412. 10.1016/j.bbamem.2010.09.020. 20888788.
14. Ghavami S. Kerkhoff C. Chazin W.J. Kadkhoda K. Xiao W. Zuse A. et al 2008. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta, 1783 (2): 297-311. 10.1016/j.bbamcr.2007.10.015. 18060880.
15. Giorgi I. Nieri P. 2013. Adenosine A1 modulators: a patent update (2008 to present). Expert Opin. Ther. Pat. 23 (9): 1109-1121. 10.1517/13543776.2013.799142. 23713589.
16. Grant M.B. Tarnuzzer R.W. Caballero S. Ozeck M.J. Davis M.I. Spoerri P.E. et al 1999. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 85 (8): 699-706. 10.1161/01.RES.85.8.699. 10521243.
17. Hashemi M. Karami-Tehrani F. Ghavami S. Maddika S. Los M. 2005. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and-negative human breast cancer cells via the intrinsic pathway. Cell Prolif. 38 (5): 269-285. 10.1111/j.1365-2184.2005.00349.x. 16202036.
18. Hua X. Chason K.D. Jania C. Acosta T. Ledent C. Tilley S.L. 2013. Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation. J. Pharmacol. Exp. Ther. 344 (2): 426-435. 10.1124/jpet.112.198978. 23149337.
19. Jajoo S. Mukherjea D. Watabe K. Ramkumar V. 2009. Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia, 11 (11): 1132. 10.1593/neo.09744. 19881949.
20. Kumar V. Sharma A. 2009. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur. J. Pharmacol. 616 (1): 7-15. 10.1016/j.ejphar.2009.05.005. 19464286.
21. 2a Receptors Increase Arterial Endothelial Cell Nitric Oxide. J. Surg. Res. 80 (2): 357-364. 10.1006/jsre.1998.5439. 9878338.
22. Merighi S. Varani K. Gessi S. Cattabriga E. Iannotta V. Ulouglu C. et al 2001. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br. J. Pharmacol. 134 (6): 1215-1226. 10.1038/sj.bjp.0704352. 11704641.
23. Nylander S. Femia E. Scavone M. Berntsson P. Asztély A.K. Nelander K. et al 2013. Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism. J. Thromb. Haemost. 11 (10): 1867-1876. 10.1111/jth.12360. 23890048.
24. Panjehpour M. Karami-Tehrani F. 2007. Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. Oncol. Res. 16 (12): 575-585. 10.3727/000000007783629981. 18351132.
25. Panjehpour M. Castro M. Klotz K.N. 2005. Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal. Br. J. Pharmacol. 145 (2): 211-218. 10.1038/sj.bjp.0706180. 15753948.
26. Panjehpour M. Movahedian A. Sadeghi H. Eghbali B. Yekdaneh A. 2012. Adenosine Receptor Expression in Two Different Human Cancer Cell Lines at Molecular Level. Iran. J. Cancer Prev. 3 (3): 111-116.
27. Poulsen S.-A. Quinn R.J. 1998. Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. 6 (6): 619-641. 10.1016/S0968-0896(98)00038-8. 9681130.
28. Rowinsky E.K. 2003. Signal events: cell signal transduction and its inhibition in cancer. Oncologist, 8 (3): 5-17. 10.1634/theoncologist.8-suppl-3-5, 10.1634/theoncologist.8-suppl-1-5, 10.1634/theoncologist.8-1-5. 14671224.
29. Sai K. Yang D. Yamamoto H. Fujikawa H. Yamamoto S. Nagata T. et al 2006. A(1) adenosine receptor signal and AMPK involving caspase-9/-3 activation are responsible for adenosine-induced RCR-1 astrocytoma cell death. Neurotoxicology, 27 (4): 458-467. 10.1016/j.neuro.2005.12.008. 16469385.
30. 1 adenosine receptors. Cancer Lett. 290 (2): 211-215. 10.1016/j.canlet.2009.09.011. 19822392.
31. Schiedel A.C. Lacher S.K. Linnemann C. Knolle P.A. Müller C.E. 2013. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms. Purinergic Signal. 9: 351-365. 10.1007/s11302-013-9354-7. 23359122.
32. Schöneberg, T., Schulz, A., and Gudermann, T. 2002. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. In Reviews of physiology, biochemistry and pharmacology. Springer. pp. 144-227.
33. Shirali S. Aghaei M. Shabani M. Fathi M. Sohrabi M. Moeinifard M. 2013. Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3. Tumur Biol. 34: 1085-1095. 10.1007/s13277-013-0650-1. 23345014.
34. Siegel R. Ma J. Zou Z. Jemal A. 2014. Cancer statistics, 2014. CA Cancer J. Clin. 64 (2): 104-117. 10.3322/caac.21220. 24639052.
35. Tai C.J. Chang S.J. Chien L.Y. Leung P.C. Tzeng C.R. 2005. Adenosine triphosphate induces activation of caspase-3 in apoptosis of human granulosa-luteal cells. Endocr. J. 52 (3): 327-335. 10.1507/endocrj.52.327. 16006727.
36. Trincavelli M.L. Marroni M. Tuscano D. Ceruti S. Mazzola A. Mitro N. et al 2004. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J. Neurochem. 91 (5): 1180-1190. 10.1111/j.1471-4159.2004.02793.x. 15569261.
37. Wei C.J. Li W. Chen J.-F. 2011. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim. Biophys. Acta, 1808 (5): 1358-1379. 10.1016/j.bbamem.2010.12.018. 21185258.
38. Wei Q. Costanzi S. Balasubramanian R. Gao Z.-G. Jacobson K.A. 2013. A2B adenosine receptor blockade inhibits growth of prostate cancer cells. Purinergic Signal. 9 (2): 271-280. 10.1007/s11302-012-9350-3. 23315335.
39. Wu L.F. Li G.P. Feng J.L. Pu Z.J. 2006. Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells. Acta Pharmacol. Sin. 27 (4): 477-484. 10.1111/j.1745-7254.2006.00302.x. 16539849.
40. 2b receptor is highly expressed in human hepatocellular carcinoma. Hepatol. Res. 36 (1): 56-60. 10.1016/j.hepres.2006.06.008. 16844405.
41. Yasuda Y. Saito M. Yamamura T. Yaguchi T. Nishizaki T. 2009. Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A2a adenosine receptors. J. Gastroenterol. 44 (1): 56-65. 10.1007/s00535-008-2273-7. 19159073.
42. Zhang Y.x. Xia D. Wang M. 2005. Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine1. Acta Pharmacol. Sin. 26 (11): 1365-1372. 10.1111/j.1745-7254.2005.00205.x. 16225760.